James D. Watson Helix Award for Biotechnology Industry Leadership
Filed in archive Corporate and Industrial News , Meetings and Other Events on February 19, 2006
During the recently concluded 8th Annual BIO CEO & Investor Conference at the Waldorf-Astoria, the Biotechnology
Industry Organization (BIO) announced this year's winners of the James D. Watson Helix Award for Biotechnology Industry Leadership.
Large Capitalization: Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization: Alnylam Pharmaceuticals Inc., of Cambridge, Mass.
International: Novo Nordisk Inc., of Princeton, N.J.
"These companies have been selected and recognized as industry leaders by being nominated by their peers. Each firm is devoting its resources to developing cutting-edge science that will lead to breakthrough, life saving therapies. I congratulate them for their success and commitment to saving and improving patient lives," said Jim Greenwood, BIO's president and CEO.
Read more about the award from BIO. You may want to view webcasts of the companies which participated at the conference here.
Tags: biotech investor biotechnology industry award biotechnology+industry james+watson award+biotechnolog
Vote for James D. Watson Helix Award for Biotechnology Industry Leadership:
|
Rating: 8.00 out of 3 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells